Literature DB >> 21915059

Placebo responses and placebo effects in functional bowel disorders.

Paul Enck1, Bjoern Horing, Katja Weimer, Sibylle Klosterhalfen.   

Abstract

The nature and determinants of the placebo response are widely unknown, as are the underlying psychological and biological mechanisms. Placebo response rates in functional bowel disorders (functional dyspepsia, irritable bowel syndrome) trials are similar to those in nonintestinal pain conditions and are comparable with other organic gastrointestinal diseases (duodenal ulcer, inflammatory bowel diseases). In this narrative review, different methodologies (meta-analyses, reanalyses, and experimental setups) are discussed that have been applied to the study of the placebo response in functional dyspepsia and the irritable bowel syndrome.

Entities:  

Mesh:

Year:  2012        PMID: 21915059     DOI: 10.1097/MEG.0b013e32834bb951

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  10 in total

Review 1.  Diagnosis and Management of Functional Heartburn.

Authors:  Christine Hachem; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2016-01-05       Impact factor: 10.864

2.  A survey of pharmacological and nonpharmacological treatment of functional gastrointestinal disorders.

Authors:  Edith Lahner; Stefano Bellentani; Rudy De Bastiani; Cesare Tosetti; Michele Cicala; Gianluca Esposito; Paolo Arullani; Bruno Annibale
Journal:  United European Gastroenterol J       Date:  2013-10       Impact factor: 4.623

3.  Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome.

Authors:  B P Chumpitazi; J L Cope; E B Hollister; C M Tsai; A R McMeans; R A Luna; J Versalovic; R J Shulman
Journal:  Aliment Pharmacol Ther       Date:  2015-06-24       Impact factor: 8.171

Review 4.  Placebo eff ects in psychiatry: mediators and moderators.

Authors:  Katja Weimer; Luana Colloca; Paul Enck
Journal:  Lancet Psychiatry       Date:  2015-03       Impact factor: 27.083

Review 5.  Effects of improved patient participation in primary care on health-related outcomes: a systematic review.

Authors:  Ariëtte R J Sanders; Inge van Weeghel; Maartje Vogelaar; William Verheul; Ron H M Pieters; Niek J de Wit; Jozien M Bensing
Journal:  Fam Pract       Date:  2013-04-29       Impact factor: 2.267

6.  A non-interventional, observational study of a fixed combination of pepsin and amino acid hydrochloride in patients with functional dyspepsia.

Authors:  Kristin Forssmann; Larissa Meier; Bernhard Uehleke; Cornelia Breuer; Rainer Stange
Journal:  BMC Gastroenterol       Date:  2017-11-25       Impact factor: 3.067

7.  Effect of administering a multi-species probiotic mixture on the changes in fecal microbiota and symptoms of irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.

Authors:  Hyuk Yoon; Young Soo Park; Dong Ho Lee; Jae-Gu Seo; Cheol Min Shin; Nayoung Kim
Journal:  J Clin Biochem Nutr       Date:  2015-06-30       Impact factor: 3.114

8.  Electroacupuncture for patients with diarrhea-predominant irritable bowel syndrome or functional diarrhea: A randomized controlled trial.

Authors:  Hui Zheng; Ying Li; Wei Zhang; Fang Zeng; Si-Yuan Zhou; Hua-Bin Zheng; Wen-Zeng Zhu; Xiang-Hong Jing; Pei-Jing Rong; Chun-Zhi Tang; Fu-Chun Wang; Zhi-Bin Liu; Shi-Jun Wang; Mei-Qi Zhou; Zhi-Shun Liu; Bing Zhu
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

Review 9.  Placebo Responses and Placebo Effects in Functional Gastrointestinal Disorders.

Authors:  Paul Enck; Sibylle Klosterhalfen
Journal:  Front Psychiatry       Date:  2020-08-25       Impact factor: 4.157

10.  The Rome IV versus Rome III criteria for heartburn diagnosis: A comparative study.

Authors:  Mengyu Zhang; Minhu Chen; Sui Peng; Yinglian Xiao
Journal:  United European Gastroenterol J       Date:  2017-09-27       Impact factor: 4.623

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.